Submitted by Anonymous (not verified) on 6 May 2025 - 15:45
Human medicines European public assessment report (EPAR): Briumvi, ublituximab, Date of authorisation: 31/05/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Briumvi, ublituximab, Date of authorisation: 31/05/2023, Revision: 6, Status: Authorised